N Matussek. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AnimalsBipolar Disorder/metabolismBrain/enzymologyCentral Nervous System/metabolismDepression/drug therapyDepression/enzymologyDepression/metabolismDihydroxyphenylalanine/metabolismDihydroxyphenylalanine/therapeutic useGlycols/urineHumansHydroxyindoleacetic Acid/cerebrospinal fluidHydroxyindoleacetic Acid/metabolismNorepinephrine/metabolismParkinson Disease/drug therapyPeripheral Nerves/metabolismPhenylacetates/cerebrospinal fluidPhenylacetates/urineSerotonin/metabolismTryptophan/metabolismTryptophan/therapeutic useTryptophan Hydroxylase/metabolism
Substances: See more » GlycolsPhenylacetatesSerotoninHydroxyindoleacetic AcidDihydroxyphenylalanineTryptophanTryptophan HydroxylaseNorepinephrine
Year: 1972 PMID: 4565920 DOI: 10.1007/bf01245319
Source DB: PubMed Journal: J Neural Transm Impact factor: 3.575